The Flowr Corporation (TSXV:FLWR) added to Canada’s cannabis history last week by hiring Dr. Deron Caplan as director of plant science. According to an article by Kelowna Now, Dr. Caplan is the first person to be granted a cannabis cultivation PhD in North America and was awarded his doctorate from the University of Guelph in August 2018, where he based his research on cannabis production.
Dr. Caplan will be working out of Flowr’s cultivation and R&D facility in Kelowna, which is 50 percent operational at this time. He is an expert in growing substrates, fertilization protocols, propagation techniques and irrigation management, which will be a benefit to both Flowr and strategic partner Hawthorne Canada Limited, a subsidiary of The Scotts Miracle-Gro Company (NYSE:SMG), as the two companies conduct R&D programs on cannabis cultivation systems.
“Flowr is focused on producing premium quality cannabis at scale with industry-leading efficiency and that requires remaining a leader in both cultivation techniques and genetics,” said Flowr co-founder Tom Flow. “We believe that adding Deron to our existing team and alliance with Hawthorne Canada strengthens our position at the forefront of understandings the tools and techniques needed to grow great cannabis.”
To view the full article, click here.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/